News
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...
This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
By 2021, nearly 2,000 volunteers had answered the call to test an experimental Alzheimer’s drug known as BAN2401. For the...
In an extraordinary 6,000-word guest editorial in the October 2024 issue of The CRISPR Journal (a sister journal of GEN, ...
Former IVF patients in the USA have filed class action lawsuits against several companies for misleading them about the efficacy...
Kendric Cromer, 12, left Children’s National Hospital in a wheelchair on Wednesday, wearing a T-shirt and cap printed with designs...
Turmoil at 23andMe, a company offering popular at-home DNA testing, has upset the industry. Following the resignation of every independent...
A US-based startup called Heliospect Genomics is charging parents tens of thousands of dollars to "screen" embryos they conceive for...
The field of clinical gene editing has a bona fide crisis on its hands—a crisis that has to, and can...
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week...



